Cargando…

Exendin-4 Ameliorates Motor Neuron Degeneration in Cellular and Animal Models of Amyotrophic Lateral Sclerosis

Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease characterized by a progressive loss of lower motor neurons in the spinal cord. The incretin hormone, glucagon-like peptide-1 (GLP-1), facilitates insulin signaling, and the long acting GLP-1 receptor agonist exendin-4 (Ex...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Yazhou, Chigurupati, Srinivasulu, Holloway, Harold W., Mughal, Mohamed, Tweedie, David, Bruestle, Daniel A., Mattson, Mark P., Wang, Yun, Harvey, Brandon K., Ray, Balmiki, Lahiri, Debomoy K., Greig, Nigel H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3285661/ https://www.ncbi.nlm.nih.gov/pubmed/22384126 http://dx.doi.org/10.1371/journal.pone.0032008

Ejemplares similares

Rivastigmine Lowers Aβ and Increases sAPPα Levels, Which Parallel Elevated Synaptic Markers and Metabolic Activity in Degenerating Primary Rat Neurons
por: Bailey, Jason A., et al.
Publicado: (2011)

Tumor necrosis factor-α synthesis inhibitor 3,6′-dithiothalidomide attenuates markers of inflammation, Alzheimer pathology and behavioral deficits in animal models of neuroinflammation and Alzheimer’s disease
por: Tweedie, David, et al.
Publicado: (2012)

Exendin-4 attenuates blast traumatic brain injury induced cognitive impairments, losses of synaptophysin and in vitro TBI-induced hippocampal cellular degeneration
por: Rachmany, Lital, et al.
Publicado: (2017)

Rivastigmine modifies the α-secretase pathway and potentially early Alzheimer’s disease
por: Ray, Balmiki, et al.
Publicado: (2020)

Correction: Rivastigmine modifies the α-secretase pathway and potentially early Alzheimer’s disease
por: Ray, Balmiki, et al.
Publicado: (2020)

Finding novel distinctions between the sAPPα-mediated anabolic biochemical pathways in Autism Spectrum Disorder and Fragile X Syndrome plasma and brain tissue
por: Ray, Balmiki, et al.
Publicado: (2016)

Human primary mixed brain cultures: preparation, differentiation, characterization and application to neuroscience research
por: Ray, Balmiki, et al.
Publicado: (2014)

Increased Secreted Amyloid Precursor Protein-α (sAPPα) in Severe Autism: Proposal of a Specific, Anabolic Pathway and Putative Biomarker
por: Ray, Balmiki, et al.
Publicado: (2011)

Exendin-4 Ameliorates Traumatic Brain Injury-Induced Cognitive Impairment in Rats
por: Eakin, Katharine, et al.
Publicado: (2013)

A Synthetic Uric Acid Analog Accelerates Cutaneous Wound Healing in Mice
por: Chigurupati, Srinivasulu, et al.
Publicado: (2010)

Autism as early neurodevelopmental disorder: evidence for an sAPPα-mediated anabolic pathway
por: Lahiri, Debomoy K., et al.
Publicado: (2013)

Exendin-4 Improves Glycemic Control, Ameliorates Brain and Pancreatic Pathologies, and Extends Survival in a Mouse Model of Huntington's Disease
por: Martin, Bronwen, et al.
Publicado: (2009)

Thalidomide Analogues Suppress Lipopolysaccharide-Induced Synthesis of TNF-α and Nitrite, an Intermediate of Nitric Oxide, in a Cellular Model of Inflammation
por: Tweedie, David, et al.
Publicado: (2011)

Cognitive Impairments Accompanying Rodent Mild Traumatic Brain Injury Involve p53-Dependent Neuronal Cell Death and Are Ameliorated by the Tetrahydrobenzothiazole PFT-α
por: Rachmany, Lital, et al.
Publicado: (2013)

Effects of microRNA-298 on APP and BACE1 translation differ according to cell type and 3′-UTR variation
por: Wang, Ruizhi, et al.
Publicado: (2022)

The Genetics of Autism
por: Sokol, Deborah K., et al.
Publicado: (2011)

Neurodevelopmental disorders and microcephaly: how apoptosis, the cell cycle, tau and amyloid-β precursor protein APPly
por: Sokol, Deborah K., et al.
Publicado: (2023)

APPlications of amyloid-β precursor protein metabolites in macrocephaly and autism spectrum disorder
por: Sokol, Deborah K., et al.
Publicado: (2023)

The RhoA-ROCK1/ROCK2 Pathway Exacerbates Inflammatory Signaling in Immortalized and Primary Microglia
por: Glotfelty, Elliot J., et al.
Publicado: (2023)

Post-treatment with PT302, a long-acting Exendin-4 sustained release formulation, reduces dopaminergic neurodegeneration in a 6-Hydroxydopamine rat model of Parkinson’s disease
por: Chen, Shuchun, et al.
Publicado: (2018)

Author Correction: Post-treatment with PT302, a long-acting Exendin-4 sustained release formulation, reduces dopaminergic neurodegeneration in a 6-Hydroxydopamine rat model of Parkinson’s disease
por: Chen, Shuchun, et al.
Publicado: (2018)

Functional characterization of a competitive peptide antagonist of p65 in human macrophage-like cells suggests therapeutic potential for chronic inflammation
por: Srinivasan, Mythily, et al.
Publicado: (2014)

Exendin-4 for Parkinson's disease
por: Esparza-Salazar, Felipe de Jesús, et al.
Publicado: (2021)

Exendin-4 as a Versatile Therapeutic Agent for the Amelioration of Diabetic Changes
por: Rajabi, Hadi, et al.
Publicado: (2022)

Exendin‐4 analogs in insulinoma theranostics
por: Jansen, Tom.J.P., et al.
Publicado: (2019)

Novel Nuclear Factor-KappaB Targeting Peptide Suppresses β-Amyloid Induced Inflammatory and Apoptotic Responses in Neuronal Cells
por: Srinivasan, Mythily, et al.
Publicado: (2016)

Glucocorticoid Induced Leucine Zipper in Lipopolysaccharide Induced Neuroinflammation
por: Witek, Emily, et al.
Publicado: (2019)

Cognitive Impairments Induced by Concussive Mild Traumatic Brain Injury in Mouse Are Ameliorated by Treatment with Phenserine via Multiple Non-Cholinergic and Cholinergic Mechanisms
por: Tweedie, David, et al.
Publicado: (2016)

Nuclear factor-kappa B: Glucocorticoid-induced leucine zipper interface analogs suppress pathology in an Alzheimer's disease model
por: Srinivasan, Mythily, et al.
Publicado: (2018)

PuF, an antimetastatic and developmental signaling protein, interacts with the Alzheimer’s amyloid-β precursor protein via a tissue-specific proximal regulatory element (PRE)
por: Lahiri, Debomoy K, et al.
Publicado: (2013)

Role of early life exposure and environment on neurodegeneration: implications on brain disorders
por: Modgil, Shweta, et al.
Publicado: (2014)

Novel upregulation of amyloid-β precursor protein (APP) by microRNA-346 via targeting of APP mRNA 5′-untranslated region: Implications in Alzheimer’s disease
por: Long, Justin M., et al.
Publicado: (2018)

Novel Roles of Amyloid-Beta Protein Precursor Metabolites in Fragile X Syndrome and Autism
por: Westmark, Cara J., et al.
Publicado: (2016)

Novel Contribution of Secreted Amyloid-β Precursor Protein to White Matter Brain Enlargement in Autism Spectrum Disorder
por: Sokol, Deborah K., et al.
Publicado: (2019)

Exendin-4 ameliorates cardiac ischemia/reperfusion injury via caveolae and caveolins-3
por: Tsutsumi, Yasuo M, et al.
Publicado: (2014)

β1 Integrin Maintains Integrity of the Embryonic Neocortical Stem Cell Niche
por: Loulier, Karine, et al.
Publicado: (2009)

A serine protease KLK8 emerges as a regulator of regulators in memory: Microtubule protein dependent neuronal morphology and PKA-CREB signaling
por: Konar, Arpita, et al.
Publicado: (2018)

Involvement of Notch Signaling in Wound Healing
por: Chigurupati, Srinivasulu, et al.
Publicado: (2007)

Effects of Exendin-4 on human adipose tissue inflammation and ECM remodelling
por: Pastel, E, et al.
Publicado: (2016)

Agraphia in Amyotrophic Lateral Sclerosis with Frontotemporal Lobe Degeneration
por: Cui, Bo, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_jt4k5akujus39tj0vjdk1cusco